ARTICLE | Company News
Ariad other research news
July 18, 1994 7:00 AM UTC
ARIAZ received a $500,000 Phase II SBIR grant from the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases to support the development of a small-molecule drug to treat osteoporosis. ...